Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia
Neurochemistry International · 2025
DOI: 10.1016/j.neuint.2025.106004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2025. Verfasst von Xiaomin Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Rel…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Paraventricular Hypothalamic Nucleus, Gastrin-Releasing Peptide, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Postdoctor Foundation of Shannxi Province, Xi'an Jiaotong University, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
BACKGROUND: Preeclampsia (PE) is a pregnancy complication associated with hypertension, whose central mechanism remains unclear. Gastrin-releasing peptide (GRP) is involved in the regulation of central blood pressure, however, whether GRP and its receptor, GRPR, in the paraventricular nucleus of the hypothalamus (PVN) are involved in blood pressure regulation in PE is unknown. METHODS: In this study, we initially assessed GRP/GRPR expression levels and their cellular distribution within the PVN of a PE rat model with reduced uterine perfusion pressure (RUPP). We investigated the effect of five-day antagonism of GRPR with ICI-216140 (1 mM/side/day, PVN microinjection) on PVN activity in this model. On gestational day 19 (GD19), the mean arterial pressure (MAP) was recorded, and samples were collected for analysis. We also investigated the effect of losartan on RUPP-induced changes in MAP and GRP/GRPR expression in the PVN. RESULTS: RUPP rats exhibited increased MAP, and GRP and GRPR expression in the PVN. GRPR antagonism with ICI-216140 attenuated RUPP intervention-increased MAP and expression of oxidative stress markers including NOX2, NOX4, and reactive oxygen species, NF-κB, and tyrosine hydroxylase in the PVN. While ICI-216140 did not affect the expression of angiotensin II receptor type 1 (AT1R), the blockade of AT1R with losartan decreased MAP 2and GRP expression in RUPP rats. CONCLUSIONS: Our findings suggest that GRP expression in the PVN mediates placental ischemia-induced hypertension and may depend on AT1R activity, which provides new pharmacological avenues for animal models of PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, 710061, Shaanxi, China.
- Shaanxi Province Blood Center, Xi'an, 710061, Shaanxi, China.
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, 710061, Shaanxi, China. Electronic address: y…
- Department of Obstetrics & Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China. Electronic address: lixuelan1225@126.com.
- Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an, 710061, Shaanxi, China. Electronic address: j…
Förderung
- Postdoctor Foundation of Shannxi Province
- Xi'an Jiaotong University
- Key Research and Development Projects of Shaanxi Province
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Xi'an Science and Technology Planning Project of Shannxi province
- Project of Independent Innovative Experiment for Postgraduates in Medicine in Xi'an Jiaotong University
- Fundamental Research Funds for the Central Universities, Xi'an Jiaotong University
Zitieren
APA
Wang, X., Ali, M. A., Liu, X., Zeng, M., Zeng, Z., Yuan, M., Issotina Zibrila, A., Liu, S., Ping, N., Kang, Y., Li, X., & Liu, J. (2025). Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.106004
Vancouver
Wang X, Ali MA, Liu X, Zeng M, Zeng Z, Yuan M, et al. Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.106004
BibTeX
@article{Wang2025,
author = {Wang, Xiaomin and Ali, Md Ahasan and Liu, Xiaoxu and Zeng, Ming and Zeng, Zhaoshu and Yuan, Meng and Issotina Zibrila, Abdoulaye and Liu, Shumin and Ping, Nana and Kang, Yuming and Li, Xuelan and Liu, Jinjun},
title = {Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia},
journal = {Neurochemistry International},
year = {2025},
doi = {10.1016/j.neuint.2025.106004}
}
EUVIMED